BioStem Technologies annual gross profit
2021
2022
2023
2024
2025
BioStem Technologies Gross Profit Growth & History (BSEM)
BioStem Technologies's gross profit was $44.4M for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $44.4M | −$11.5M | −20.52% |
| 2024 | 2024-12-31 | $55.9M | $40.5M | +262.50% |
| 2023 | 2023-12-31 | $15.4M | $9.4M | +157.36% |
| 2022 | 2022-12-31 | $6.0M | $3.1M | +109.12% |
| 2021 | 2021-12-31 | $2.9M | — | — |
BioStem Technologies quarterly gross profit
Q4.24
Q1.25
Q2.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.8M | −$5.4M | −52.90% |
| Q1 2026 | 2026-03-31 | $4.6M | −$55.9M | −92.43% |
| Q3 2025 | 2025-09-30 | $9.3M | — | — |
| Q2 2025 | 2025-06-30 | $10.3M | — | — |
| Q1 2025 | 2025-03-31 | $60.4M | — | — |
| Q4 2024 | 2024-12-31 | $99.3M | — | — |
BioStem Technologies gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's gross profit increased from $2.9M to $44.4M, a change of $41.6M. The latest reported quarter, Q2 2026, shows $4.8M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗